Renal Clearance Studies

Regarded by some as the clearance experts, DCR’s two clinical pharmacology centers offer a broad range of experience within the clinical pharmacology space

Ready access to DaVita® owned hemodialysis and peritoneal dialysis centers

  • Allows for simplified 24-hour monitoring when conducting dialysis studies
  • Provides condensed project feasibility by allowing access to our proprietary database system across multiple disease states

Highly specialized trials with focused subject population requiring specific conditions

  • Conducted more than 90 such trials in the last five years
  • Enrolled 885 subjects with an average enrollment timeframe of 2-5 months

DCR’s team is headed by Harry Alcorn, Jr., PharmD, Chief Scientific Officer

  • Conducted over 300 renal protocols
  • Enrolled over 8,000 subjects with mild, moderate, or severe renal function and those on hemo/peri dialysis